mirtazapine has been researched along with Hallucinations in 11 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He developed severe pseudohallucinations under a treatment with moclobemide." | 7.73 | Pseudohallucinations associated with moclobemide: a case report. ( Degner, D; Grohmann, R; Kropp, S; Porzig, J; Rüther, E, 2005) |
| " He developed severe pseudohallucinations under a treatment with moclobemide." | 3.73 | Pseudohallucinations associated with moclobemide: a case report. ( Degner, D; Grohmann, R; Kropp, S; Porzig, J; Rüther, E, 2005) |
| " Adverse events were commonly seen in the oncology population." | 1.72 | Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients. ( Burger, A; Eladghm, N; Gamaleldin, A; Marie Gavioli, E; Vider, E, 2022) |
| "Haloperidol was discontinued, but mirtazapine was continued, and the vivid dream activity persisted; however, reality testing when awake was intact." | 1.36 | Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment. ( Felthous, AR; Hoevet, R; Wenger, PJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Marie Gavioli, E | 1 |
| Burger, A | 1 |
| Gamaleldin, A | 1 |
| Eladghm, N | 1 |
| Vider, E | 1 |
| Ferrari, V | 1 |
| Fontecedro, E | 1 |
| Balestrieri, M | 1 |
| Sambataro, F | 1 |
| Waltereit, R | 1 |
| Eifler, S | 1 |
| Schirmbeck, F | 1 |
| Zink, M | 1 |
| Tagai, K | 2 |
| Nagata, T | 2 |
| Shinagawa, S | 2 |
| Tsuno, N | 1 |
| Ozone, M | 1 |
| Nakayama, K | 2 |
| Auffarth, IS | 1 |
| Kropp, S | 2 |
| Felthous, AR | 1 |
| Wenger, PJ | 1 |
| Hoevet, R | 1 |
| Padala, KP | 1 |
| Padala, PR | 1 |
| Malloy, T | 1 |
| Burke, WJ | 1 |
| Siddiqui, Z | 1 |
| Ramaswmay, S | 1 |
| Petty, F | 1 |
| Degner, D | 1 |
| Porzig, J | 1 |
| Grohmann, R | 1 |
| Rüther, E | 1 |
| Koethe, D | 1 |
| Dietl, T | 1 |
| Leweke, FM | 1 |
| Friess, E | 1 |
11 other studies available for mirtazapine and Hallucinations
| Article | Year |
|---|---|
Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients.
Topics: Adult; Aged; Anorexia; Appetite; Appetite Stimulants; Cachexia; Hallucinations; Humans; Long QT Synd | 2022 |
A Case of Visual Illusions Secondary to Mirtazapine Treatment.
Topics: Aged, 80 and over; Feeding and Eating Disorders; Hallucinations; Humans; Illusions; Male; Mirtazapin | 2020 |
Visual and auditory hallucinations associated with citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive D | 2013 |
Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Topics: Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Female; Halluc | 2013 |
Musical hallucination in a patient after cochlear implantation.
Topics: Aged; Cochlear Implantation; Deafness; Female; Hallucinations; Humans; Mianserin; Mirtazapine; Music | 2009 |
Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Depressive Disorder, Major; Dreams; Ha | 2010 |
New onset multimodal hallucinations associated with mirtazapine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Hallucinatio | 2010 |
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
Topics: Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Depressive Disorder; Female; Hallucination | 2013 |
Mirtazapine for Charles Bonnet syndrome.
Topics: Antidepressive Agents, Tricyclic; Hallucinations; Humans; Male; Mianserin; Middle Aged; Mirtazapine; | 2004 |
Pseudohallucinations associated with moclobemide: a case report.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Hallucinations; Humans; Male; Mianserin; Mirtazap | 2005 |
Cessation of complex visual hallucinations during treatment with mirtazapine.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Hallucinations; Humans; Mianserin; Middl | 2007 |